DGAP-News

MorphoSys to Host Q1 2017 Conference Call on May 3, 2017

DGAP-News: MorphoSys AG / Key word(s): Interim Report MorphoSys to Host Q1 2017 Conference Call on May 3, 2017 (news with additional features) 24.04.2017 / 15:00 The issuer is solely responsible for the content of this announcement. MorphoSys to Host Q1 2017 Conference Call on May 3, 2017

MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX) will publish its first three months' 2017 results on May 3, 2017 at 7:00 am CEST.

At 3:00 pm CEST (2:00 pm BST, 9:00 am EDT), the Management Board of MorphoSys AG will host a public conference call and webcast to present MorphoSys's first quarter interim statement 2017 and provide further details on the Company's latest developments.

Dial-in numbers (listen only):

Germany: [phone]

United Kingdom: [phone]

USA: [phone]

We request that you please dial in up to 10 minutes before the call to ensure a prompt start and a secure line.

The presentation slides and webcast link will be available at the Company's website at www.morphosys.com/conference-calls

A slide-synchronized audio replay of the conference will also be available at the corporate website following the live event.

The Annual General Meeting of MorphoSys AG will take place on May 17, 2017 in Munich. A live webcast of the event and all related information are available on www.morphosys.com/agm.

 

About MorphoSys:

MorphoSys developed HuCAL, the most successful antibody library technology in the pharmaceutical industry. By successfully applying this and other patented technologies, MorphoSys has become a leader in the field of therapeutic antibodies, one of the fastest-growing drug classes in human healthcare.

Together with its pharmaceutical partners, MorphoSys has built a therapeutic pipeline of more than 100 human antibody drug candidates for the treatment of cancer, rheumatoid arthritis, and Alzheimer's disease, to name just a few. With its ongoing commitment to new antibody technology and drug development, MorphoSys is focused on making the healthcare products of tomorrow. MorphoSys is listed on the Frankfurt Stock Exchange under the symbol MOR. For regular updates about MorphoSys, visit http://www.morphosys.com.